Biofrontera on the Move: Company Raises $16M, Reduces Ameluz Transfer Price
Biofrontera has entered into a securities purchase agreement with healthcare-focused institutional investors led by Rosalind Advisors. The Company raised financing of $8M with an additional $8M tied to milestones for aggregate proceeds of $16M gross priced at market per Nasdaq rules. The stock soared with the announcement, according to media reports. This private placement is […]